Dr. Marc Shepard, MD

Dr. Shepard practices at Medstar Medical Group II in Arlington, Virginia.

Dr. Shepard's NPI, 1770673824, was assigned on October 12, 2006. Dr. Shepard holds District of Columbia license MD12080.

Dr. Shepard's primary practice is Medstar Medical Group II, at 2000 15th N St, Arlington, VA 22201 in Arlington County. The practice phone is (443) 444-5606.

Dr. Shepard's primary practice is Medstar Medical Group II in Arlington, Virginia. Dr. Shepard is also affiliated with MedStar Washington Hospital Center. The medical group on file is Signify Health. Dmand AI also links Dr. Shepard to 5 more medical groups, 2 group practices and clinics, 1 physician office and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shepard practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Shepard's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Shepard's licenses on file in 3 states: District of Columbia, Maryland and New York.

CMS data shows 243 Medicare services from Dr. Shepard across 4 procedure codes in 2024, for 119 Medicare patients. Medicare paid $21,045 for them. Every service was in an office.

CMS counts 119 Medicare patients who saw Dr. Shepard in 2024. The largest group is 75 to 84, with 51 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 0.95, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Shepard's median patient age at 60, with 49% women.

In 2024, Dr. Shepard wrote 3,474 Medicare Part D claims for 321 patients. 86% of them were for generic drugs. CMS names the drug for 2,908 of them, across 95 drugs with 11 or more claims each, at $250,863 in total drug cost. In 2023, CMS named 2,572 claims across 86 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Shepard for performance year 2024, reported as part of a group. Dr. Shepard accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shepard as offering telehealth.

Dmand AI links 1 paper to Dr. Shepard in 2011. Dr. Shepard's most frequent co-authors are Charles M. Fogarty, MD and Eric A. Sheldon, MD.

Dmand AI links Dr. Shepard to 1 clinical trial. Conditions studied include Diabetes Mellitus, Type 2 and Diabetes Mellitus. Open Payments lists research payments to Dr. Shepard that name 1 trial.

CMS Open Payments shows 119 general payments to Dr. Shepard from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 85% of the total. Novo Nordisk Inc paid the most, $3,546. It also lists 4 research payments totaling $13,059 from 2018 to 2019, naming 1 clinical trial.